Our article, Current Trends in Pharmacogenomics that will shape Clinical Trials, has been published in Issue 47 of Pharma Focus Asia Magazine. Authored by our Global Head of Generics, Ayaaz Hussain Khan, the article addresses the increased relevance of pharmacogenomics in explaining individual differences in drug responses, with the market’s projected growth to $9,346.8 million by 2031, and explores the changing clinical trial landscape as a result.

Please complete the form to download the article and learn more.

Published in Pharma Focus Asia Issue 47 – 2022 | Pages 48 - 51

© 2022 Navitas Life Sciences | Privacy Policy